NORTHERN TRUST CORP - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 225 filers reported holding BRIDGEBIO PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.6%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$30,428,739
+56.7%
1,153,915
+2.2%
0.01%
+50.0%
Q2 2023$19,423,479
+22.4%
1,129,272
+18.0%
0.00%
+33.3%
Q1 2023$15,872,979
+121.3%
957,357
+1.7%
0.00%
+50.0%
Q4 2022$7,171,700
-22.9%
941,168
+0.5%
0.00%0.0%
Q3 2022$9,305,000
+6.0%
936,038
-3.2%
0.00%0.0%
Q2 2022$8,776,000
-13.3%
966,551
-3.1%
0.00%0.0%
Q1 2022$10,123,000
-40.0%
997,290
-1.4%
0.00%
-33.3%
Q4 2021$16,877,000
-67.7%
1,011,768
-9.3%
0.00%
-66.7%
Q3 2021$52,279,000
-20.5%
1,115,399
+3.5%
0.01%
-25.0%
Q2 2021$65,719,000
+3.7%
1,078,063
+4.8%
0.01%0.0%
Q1 2021$63,387,000
+7.0%
1,029,010
+23.6%
0.01%0.0%
Q4 2020$59,222,000
+85.1%
832,836
-2.3%
0.01%
+71.4%
Q3 2020$31,988,000
+24.1%
852,540
+7.9%
0.01%
+16.7%
Q2 2020$25,776,000
+13.7%
790,437
+1.1%
0.01%
-14.3%
Q1 2020$22,677,000
+110.1%
781,982
+154.0%
0.01%
+250.0%
Q4 2019$10,792,000
+68.2%
307,924
+3.0%
0.00%0.0%
Q3 2019$6,418,000298,8910.00%
Q2 2019$000.00%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$160,016,45665.94%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$819,077,80528.79%
Cormorant Asset Management, LP 4,662,530$122,950,9167.17%
Frazier Life Sciences Management, L.P. 2,725,949$71,883,2754.77%
Octagon Capital Advisors LP 971,639$25,622,1203.94%
M28 Capital Management LP 121,200$3,196,0443.66%
VIKING GLOBAL INVESTORS LP 25,120,991$662,440,5332.69%
BOONE CAPITAL MANAGEMENT LLC 313,381$8,263,8572.61%
Fernwood Investment Management, LLC 235,620$6,213,2992.23%
SOUTHPORT MANAGEMENT, L.L.C. 15,000$395,5502.15%
View complete list of BRIDGEBIO PHARMA INC shareholders